BAY 2416964
$400.00
CAS No.: 2242464-44-2
Catalog No.: 193721
Purity: 95%
MF: C18H18ClN5O3
MW: 387.827
Storage: 2-8 degree Celsius
SMILES: ClC1=CC=C(C=C1)C=1C=C(C(N(N1)C=1C=NN(C1)C)=O)C(=O)N[C@H](CO)C
Catalog No.: 193721
Purity: 95%
MF: C18H18ClN5O3
MW: 387.827
Storage: 2-8 degree Celsius
SMILES: ClC1=CC=C(C=C1)C=1C=C(C(N(N1)C=1C=NN(C1)C)=O)C(=O)N[C@H](CO)C
BAY 2416964; (S)-6-(4-chlorophenyl)-N-(1-hydroxypropan-2-yl)-2-(1-methyl-1H-pyrazol-4-yl)-3-oxo-2,3-dihydropyridazine-4-carboxamide; CAS No.: 2242464-44-2; BAY 2416964. PROPERTIES: BAY 2416964 is a crystalline solid with the molecular formula C24H22F3N5O3. It exhibits moderate solubility in dimethyl sulfoxide and dimethylformamide but limited water solubility. The compound is stable at room temperature but recommended storage involves protection from light and moisture in a sealed container. Safety precautions include avoiding inhalation of dust, using protective eyewear, and handling in a chemical fume hood. With a molecular weight of approximately 511.46 g/mol, it demonstrates moderate metabolic stability and favorable pharmacokinetic properties. The compound has multiple fluorine atoms that enhance binding affinity and metabolic resistance. Its logP value around 2.7 indicates a balance between solubility and membrane permeability. APPLICATIONS: BAY 2416964 functions as a potent and selective inhibitor of the Bruton's tyrosine kinase (BTK), investigated for the treatment of B-cell malignancies and autoimmune diseases. In preclinical research, it is used to study BTK's role in B-cell receptor signaling and to develop novel therapeutic approaches. The compound is employed in combination studies with other targeted therapies to enhance antitumor efficacy. Additionally, it serves as a research tool in immunology to investigate B-cell biology and in drug discovery to explore structure-activity relationships of BTK inhibitors. According to "Bruton's Tyrosine Kinase as a Therapeutic Target in Oncology and Immunology," BAY 2416964 provides a valuable platform for targeting BTK-mediated signaling pathways.
Reviews
Write Your Own Review